FLC is a rare liver cancer with unique genetic traits, often misdiagnosed until advanced. New research and a clinical trial ...

Salk scientists have found that eliminating the bile acid-producing protein BAAT and supplementing with the bile acid UDCA ...

New insights into fibrolamellar hepatocellular carcinoma could lead to new drugs and significantly improved health outcomes.

The findings, published in Science, help explain why immune cells behave differently in different tumor environments and ...

Like many rare diseases, fibrolamellar hepatocellular carcinoma (FLC) mounts a ferocious attack against an unlucky few-in this case, children, adolescents, and young adults.

The targeting of telomeres offers promise for new cancer therapies, which can be aimed at disrupting the mechanisms that ...

Histological section of an FLC tumor, showing the stromal (left), normal (center), and tumor (right) cells. The colors correspond to gene markers ...

Immunotherapy is a modern approach to cancer treatment that uses a patient's own immune system to help fight tumors. It has ...

Two independent studies reveal that disease progression is delayed by combining two targeted therapies with the traditional ...

Cancer metastasis—the spread of cancer to other organs—is the leading cause of death among cancer patients. Researchers have ...

Jan. 17, 2025 — Long classified as a subset of common liver cancer ... A Battle of Rafts: How Molecular Dynamics in CAR T Cells Explain Their Cancer-Killing Behavior Jan. 10, 2025 — A study ...

The number of people dying from liver cancer has nearly doubled in the past two decades and is projected to keep rising, new analysis shows, despite around half of cases being preventable.